Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trialsTimothy A. Yap, Marina Konopleva, Meghan Collins et al.|Nature Medicine|2023Cited by 372
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemiaQi Zhang, Marina Konopleva|Signal Transduction and Targeted Therapy|2022Cited by 177
Mosaic loss of chromosome Y promotes leukemogenesis and clonal hematopoiesisQi Zhang, Chong Chen|JCI Insight|2022Cited by 53
Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter studyGuo‐Tian Ruan, Hanping Shi, Hailun Xie et al.|BMC Cancer|2022Cited by 19